➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Medtronic
Dow
Johnson and Johnson
AstraZeneca

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

Pseudoephedrine hydrochloride; triprolidine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of patent protection?

Pseudoephedrine hydrochloride; triprolidine hydrochloride is the generic ingredient in twelve branded drugs marketed by Glaxosmithkline, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Fosun Pharma, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for pseudoephedrine hydrochloride; triprolidine hydrochloride.

Summary for pseudoephedrine hydrochloride; triprolidine hydrochloride
US Patents:0
Tradenames:12
Applicants:13
NDAs:16
Drug Master File Entries: 49
DailyMed Link:pseudoephedrine hydrochloride; triprolidine hydrochloride at DailyMed

US Patents and Regulatory Information for pseudoephedrine hydrochloride; triprolidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES pseudoephedrine hydrochloride; triprolidine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 071798-001 Mar 16, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Superpharm TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088578-001 Feb 21, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
West Ward TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088117-001 Apr 19, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Newtron Pharms TRILITRON pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088474-001 Feb 12, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline ACTIFED pseudoephedrine hydrochloride; triprolidine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018996-001 Jun 17, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.